Evidence map›Paper›PMID 42298299›Full record

ArticleThe Journal of dermatology2026

Analysis of Phosphorylated MEK1 Expression Pattern in Cutaneous Dilated Vessels of Capillary Malformations.

Michihiro Takiwaki, Kayo Kunimoto, Yumi Nakatani, Ken Miyazaki, Tokiyoshi Ikoma, Kana Sakai, Yuna Noda, Yutaka Inaba, Yuki Yamamoto, Masatoshi Jinnin

Abstract read
In one paragraph

Article in The Journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michihiro TakiwakiDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.ORCID https://orcid.org/0009-0003-4064-6690
Kayo KunimotoDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.
Yumi NakataniDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.
Ken MiyazakiDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.
Tokiyoshi IkomaDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.
Kana SakaiDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.
Yuna NodaDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.
Yutaka InabaDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.ORCID https://orcid.org/0000-0003-2030-467X
Yuki YamamotoDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.
Masatoshi JinninDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanism of capillary malformation (CM) is thought to be the abnormal dilation of capillaries as a result of activation of the RAS-RAF-MEK-ERK pathway due to GNAQ/GNA11 gene mutations. However, no prior studies have actually demonstrated phosphorylation of MEK in CM. CMs were classified into three types according to clinical and histopathological findings: Flat, hypertrophic, and nodular. Comparison of the expression pattern of phosphorylated MEK1 (p-MEK1) in these three types of CMs revealed that p-MEK1 staining was positive in dilated capillaries in the upper dermis of the flat CMs. Double staining was performed to determine which cells of CM expressed p-MEK1: CD34 and p-MEK1 showed partial co-localization, demonstrating that p-MEK1 is expressed in the vascular endothelial cells. Both p-MEK1-positive and p-MEK1-negative vessels were observed in dilated vessels of CM. In addition, p-MEK1-positive vessels may be present deeper than anticipated. JNK and ERK were also phosphorylated in the dilated vessels. Furthermore, in contrast to the flat type and hypertrophic type of CM, the nodular type showed no p-MEK1 expression in its proliferated capillaries, supporting the notion that nodular CMs arise via a distinct mechanism. Taken together, our results indicated that visualization of affected vessels of CM using p-MEK1 immunostaining is useful not only for diagnosis but also for understanding the pathogenesis of CM.

Indexed as

CapillariesMAP Kinase Kinase 1Vascular MalformationsEndothelial CellsHumansImmunohistochemistryPhosphorylationSkinMAP2K1 protein, humanMAP Kinase Kinase 1capillary malformationimmunofluorescenceimmunohistochemical stainingp‐MEK1

Identifiers

PMID42298299
PMCPMC13435112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.